Less Ads, More Data, More Tools Register for FREE

Pin to quick picksALD.L Regulatory News (ALD)

  • There is currently no data for ALD

Directorate Change

13 Dec 2017 07:00

RNS Number : 1515Z
Aldermore Group PLC
13 December 2017
 

13 December 2017

LEI: 213800JQLWHE8NQYXX31

Aldermore Group PLC (the "Company")

 

APPOINTMENT OF CHAIRMAN

Aldermore Group PLC is pleased to announce the appointment of Pat Butler as a Non-Executive Director with effect from 1 January 2018 and as Chairman designate. Pat will also be appointed as a Non-Executive Director and Chairman designate of Aldermore Bank PLC.

On 8 December 2017 shareholders voted in favour of accepting FirstRand's offer for the Company. To provide continuity through the ensuing process, it is expected that Pat's appointment as Chairman will take effect following completion of the acquisition. On appointment as Chairman, Pat will also chair the Corporate Governance and Nomination Committee, and be appointed as a member of the Remuneration Committee.

Pat brings extensive financial services experience to the Board, gained through both his executive and non-executive careers. Pat currently serves as an independent Non-Executive Director of Bank of Ireland Group PLC and Bank of Ireland (UK) PLC, where he chairs the Remuneration Committee; of Hikma Pharmaceuticals PLC, where he is Chairman of the Audit Committee; and of the Ardonagh Group Limited, where he chairs the Risk Committee.

He was previously a Partner at The Resolution Group, which conducts investment and restructuring activities in financial services. He also chaired the Investment Committee of British Business Bank Investments Ltd, which is the commercial arm of British Business Bank.

Pat previously spent a number of years at McKinsey & Company, where he held senior roles including leading the Europe, Middle East and Africa Retail Financial Services Practice.

Danuta Gray will continue in her role as Interim Chairman until the effective date of Pat's appointment as Chairman, at which point she will resume her role as Senior Independent Director of the Board with effect from the same date.

Danuta Gray, Interim Chairman, said, "I am delighted that Pat has decided to join Aldermore. He brings a proven track record in financial services and his appointment is a key step in our journey. I would like to welcome Pat to the Company and I look forward to working with him to ensure a smooth transition before his appointment takes effect."

Pat Butler, Chairman designate, said, "I am excited to be joining Aldermore as it moves towards the next phase of its journey and the opportunities that lie ahead. I would like to congratulate Danuta in her exemplary leadership over the past year and her management of the FirstRand offer which greatly enhances the strategic opportunities of the Company."

There is no other information to be disclosed under the requirements of Listing Rule 9.6.13R in relation to this appointment.

For further information:

Rachel Spencer

Company Secretary

+44 (0)20 3553 4202

 

Martin Adams

Director of Financial Planning & Analysis and Investor Relations

+44 (0)20 8185 3108

 

Holly Marshall

Director of Corporate Affairs

+44 (0)7557 391682

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAGMMMZRZGGNZM
Date   Source Headline
17th Oct 201711:25 amRNSForm 8.5 (EPT/RI) Aldermore Group plc
17th Oct 201711:19 amRNSForm 8.5 (EPT/NON-RI) Aldermore Group plc
17th Oct 201711:19 amRNSForm 8.3 - Aldermore Group Plc
17th Oct 201710:42 amRNSForm 8.3 - Aldermore Group
17th Oct 201710:24 amRNSForm 8.5 (EPT/RI) - Aldermore Group plc
17th Oct 201710:20 amRNSForm 8 (DD) - Aldermore Group plc
17th Oct 201710:19 amRNSForm 8 (DD) - Aldermore Group plc
17th Oct 20179:20 amRNSForm 8.3 - Aldermore Group plc
16th Oct 20174:30 pmRNSForm 8.3 - Aldermore Group Plc
16th Oct 20173:25 pmBUSForm 8.3 - Aldermore Group PLC
16th Oct 20173:20 pmRNSForm 8.3 - Aldermore Group PLC
16th Oct 20172:40 pmRNSForm 8.3 - Aldermore Group Plc
16th Oct 20172:39 pmRNSForm 8.3 - Aldermore Group plc
16th Oct 20172:04 pmRNSForm 8.3 - Aldermore Group Plc
16th Oct 20171:56 pmRNSForm 8.3 - [Aldermore Group plc]
16th Oct 201711:54 amRNSForm 8 (DD) - Aldermore Group plc
16th Oct 201711:50 amRNSForm 8 (DD) - Aldermore Group plc
16th Oct 201711:46 amRNSForm 8.3 - Aldermore Group plc
16th Oct 201711:40 amRNSForm 8.5 (EPT/RI) Aldermore Group Plc
16th Oct 201711:39 amRNSForm 8.5 (EPT/NON-RI) Aldermore Group Plc
16th Oct 201710:59 amRNSForm 8.5 (EPT/RI) - Aldermore Group plc
16th Oct 20179:59 amRNSForm 8.3 - Aldermore Group PLC
16th Oct 20179:33 amPRNForm 8.3 - Aldermore Group PLC
16th Oct 20177:00 amRNSFurther Statement re Possible Offer for Aldermore
13th Oct 20171:30 pmRNSStatement re possible offer for Aldermore GroupPLC
13th Oct 201712:18 pmRNSStmnt re Share Price Movement
29th Sep 20173:04 pmRNSTotal Voting Rights
31st Aug 201711:28 amRNSBlock Listing Application
17th Aug 201710:44 amRNSHolding(s) in Company
14th Aug 20179:41 amRNSHolding(s) in Company
10th Aug 20177:00 amRNSHalf-year Report
1st Aug 20174:58 pmRNSDirectorate Change
3rd Jul 201710:52 amRNSHolding(s) in Company
16th May 20173:37 pmRNSResult of AGM
16th May 20179:00 amRNSDirectorate Change
12th May 20176:04 pmRNSDirector/PDMR Shareholding
11th May 20177:00 amRNSQ1 2017 Interim Management Statement
6th Apr 201710:03 amRNSRedemption of Notes
4th Apr 20172:02 pmRNSAnnual Financial Report and Notice of AGM
31st Mar 20173:12 pmRNSTotal Voting Rights
31st Mar 20172:17 pmRNSDirector/PDMR Shareholding
24th Mar 20179:19 amRNSDirector Declaration
16th Mar 201710:27 amRNSAdditional Listing
15th Mar 201710:11 amRNSHolding(s) in Company
10th Mar 20177:00 amRNSResult of the placing in Aldermore Group plc
9th Mar 20175:12 pmRNSProposed placing of Aldermore Group PLC shares
7th Mar 20175:00 pmRNSDirector Declaration
7th Mar 20174:59 pmRNSHolding(s) in Company
2nd Mar 20177:00 amRNSAnnual Financial Report
31st Jan 20175:13 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.